from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0548c/menB

LFCtreatmentdescriptionclass of inhibitor

-1.450

Amikacinug/mL Amikacintranslation

-0.794

Cap5-10ug/mL Capreomycintranslation

-2.401

Rox10-50 ug/mL Roxithromycintranslation

0.026

SM2-5 ug/mL Streptomycintranslation

-1.100

Tet5-10 ug/mL Tetracyclinetranslation

-1.119

Rif0.2-5ug/mL Rifampicintranscription

0.130

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.613

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.717

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.440

CPZ10-50 ug/mL Chlorpromazinerespiration

0.595

Clofazimine10-13 ug/mL Clofaziminerespiration

0.593

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.262

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.067

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.163

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.005

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.131

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.884

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.338

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.441

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.058

KCN5-20 ug/mL Potassium cyaniderespiration

0.202

NaN30.2-2 mM Sodium aziderespiration

1.159

Nigericin50 uM Nigericinrespiration

-0.296

TRC10-150 ug/mL Triclosanrespiration

-0.019

TRZ10-25 ug/mL Thioridazinerespiration

-1.246

Valinomycin0.5-10 uM Valinomycinrespiration

1.274

ZnSO42 mM ZnSO4respiration

0.066

menadione6-10 ug/mL Menadionerespiration

-0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.366

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.819

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.129

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.818

NRP_1Non-replicating persistence stage 1dosRassociated

0.486

Amp0.2mg/mL AmpicillincellWall

0.298

Cephalexin20-100 ug/mL CephalexincellWall

0.467

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.194

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.240

EMB10-20 ug/mL EthambutolcellWall

-0.090

Eta12-40 ug/mL EthionamidecellWall

0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

0.059

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.425

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.219

BZA0.12 mg/mL BenzamidearomaticAmides

-0.063

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.023

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.533

H2O24 mM hydrogen peroxideDNAdamaging

0.770

Levo10 ug/mL LevofloxacinDNAdamaging

0.267

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.533

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.822

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.304

UVUV-irradiationDNAdamaging

-1.207

ARP41-4 ug/mL Antitubercular compound ARP4?

0.589

Antimycin12.5-50 ug/mL Antimycin A?

0.595

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.223

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.066

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.091

PA8240.2-2 ug/mL PA-824?

-0.293

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.522

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.776

Verapamil50 uM Verapamil?

0.821

mercaptoethanol2 mM 2-Mercaptoethanol?

0.349

methoxatin10-20 ug/mL Methoxatin?